Recent Posts

1. 

   Sotyktu floundering

   All very valid points. You forgot that RMK’s are useless as well. I think there are changes coming next week. I think the RMK’s, DAL, and MSL roles will be affected heavily just like back in August with the GI/MS teams. I don’t want to see...

   Bristol-Myers Squibb

   anonymous

   Apr 20, 2024 at 10:16 AM

2. 

   abbott diabetics

   Let’s be honest…. Abbott in general has always been the poster child for elevating minorities into leadership roles. Not speaking in absolutes here by saying all of them are bad or unqualified but a fair share of them do fit into that category....

   Abbott

   anonymous

   Apr 20, 2024 at 10:15 AM

3. 

   Amneal

   It is like one big high school click.The company an the people in management suck. Run from this toxic place!

   Impax Labs/Global

   anonymous

   Apr 20, 2024 at 10:07 AM

4. 

   Migraine Expansion Positions

   ???

   Lundbeck

   anonymous

   Apr 20, 2024 at 10:05 AM

5. 

   Vaccines reorg?

   A reorganization of the VBU should be a good thing. We need to adapt to changing market conditions, optimize resources, improve customer engagement, manage costs, align with strategic goals, and enhance overall performance. Is this a bad thing,...

   GlaxoSmithKline

   anonymous

   Apr 20, 2024 at 10:04 AM

6. 

   Bye bye Sumitomo

   Jobs here have turned into bridge jobs now. You’re fine if you stay 6-12 months to receive a fat severance payout and roll into a new job but it’s foolish to think this place is anything more at this point.

   Sunovion

   anonymous

   Apr 20, 2024 at 9:58 AM

7. 

   25 by 25

   Albert definitely has to go, is a complete fraud, failure. But if the board really wants things to change under a new CEO, they also have to get rid of other high level, long time employees that are a big part of the problem, like Sally Sussman....

   Pfizer

   anonymous

   Apr 20, 2024 at 9:47 AM

8. + Show More